Professor of Medicine, The University of Texas MD Anderson Cancer Center
Maura Gillison, MD, PhD, is Professor of Medicine and a CPRIT scholar at The University of Texas MD Anderson Cancer Center, recruited from Ohio State in March 2017. She is a head and neck medical oncologist and a molecular epidemiologist. Her laboratory focuses on the role of human papillomavirus (HPV) infection in head and neck malignancies. Her work ranges from cohort studies of oral HPV infection to genetic indicators of response to chemoradiotherapy.
She is a physician scientist and has made significant contributions to the identification of human papillomavirus as a cause of a distinct subset of head and neck cancer, resulting in a paradigm shift in concepts for risk, diagnosis and therapy of head and neck cancer. As a doctorate-level trained molecular epidemiologist and medical oncologist with expertise in head and neck cancer, she currently investigate the implications of our findings for primary and secondary prevention strategies, diagnostics, prognostics, genomics, molecular therapeutics, clinical decision making and population-level cancer incidence trends in the United States and worldwide.
Dr Gillison earned her MD from the Johns Hopkins School of Medicine, then served successively as a postdoctoral fellow at the Johns Hopkins Hospital, as a medical resident at Massachusetts General Hospital, and as a clinical fellow and later as a senior clinical fellow in oncology at Johns Hopkins before earning her PhD from that University’s School of Hygiene and Public Health. She rose to the rank of Associate Professor on faculty at Johns Hopkins Schools of Medicine and Public Health prior to her departure.
Dr Gillison is supported by grants from the National Institute of Health and CPRIT and has published extensively in such prestigious journals as The New England Journal of Medicine, Journal of the National Cancer Institute, and Journal of Clinical Oncology.